Krebs Biochemicals & Industries has received an approval for raising of funds by way of offer and issue of Equity Shares to the members of the company on rights basis (Rights Issue) at such price and rights entitlement ratio as may be decided by the Board/committee of the Board, for an amount aggregating up to Rs 25 crore. The Board of Directors of the company in its meeting on July 30, 2018, approved the same.
Krebs Biochemicals & Industries is an India-based company. The Company operates in the pharma segment.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: